These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22971960)

  • 21. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
    Dvorak-Ewell M; Wendt D; Hague C; Christianson T; Koppaka V; Crippen D; Kakkis E; Vellard M
    PLoS One; 2010 Aug; 5(8):e12194. PubMed ID: 20808938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycosaminoglycans in mucopolysaccharidoses and other disorders.
    Khan SA; Nidhi F; Leal AF; Celik B; Herreño-Pachón AM; Saikia S; Benincore-Flórez E; Ago Y; Tomatsu S
    Adv Clin Chem; 2024; 122():1-52. PubMed ID: 39111960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of brain pathology in heparan sulphate storing mucopolysaccharidoses.
    Derrick-Roberts A; Kaidonis X; Jackson MR; Liaw WC; Ding X; Ong C; Ranieri E; Sharp P; Fletcher J; Byers S
    Mol Genet Metab; 2020; 131(1-2):197-205. PubMed ID: 32739280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucopolysaccharidosis IVA: Current Disease Models and Drawbacks.
    Leal AF; Alméciga-Díaz CJ; Tomatsu S
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses.
    Minami K; Morimoto H; Morioka H; Imakiire A; Kinoshita M; Yamamoto R; Hirato T; Sonoda H
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Barrera LA; Kida K; Kubota M; Orii T
    Mol Genet Metab; 2010 Feb; 99(2):124-31. PubMed ID: 19932038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans.
    Arunkumar N; Vu DC; Khan S; Kobayashi H; Ngoc Can TB; Oguni T; Watanabe J; Tanaka M; Yamaguchi S; Taketani T; Ago Y; Ohnishi H; Saikia S; Álvarez JV; Tomatsu S
    Diagnostics (Basel); 2021 Jul; 11(8):. PubMed ID: 34441282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses.
    Tomatsu S; Gutierrez MA; Ishimaru T; Peña OM; Montaño AM; Maeda H; Velez-Castrillon S; Nishioka T; Fachel AA; Cooper A; Thornley M; Wraith E; Barrera LA; Laybauer LS; Giugliani R; Schwartz IV; Frenking GS; Beck M; Kircher SG; Paschke E; Yamaguchi S; Ullrich K; Isogai K; Suzuki Y; Orii T; Noguchi A
    J Inherit Metab Dis; 2005; 28(5):743-57. PubMed ID: 16151906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate.
    Trabszo C; Ramms B; Chopra P; Lüllmann-Rauch R; Stroobants S; Sproß J; Jeschke A; Schinke T; Boons GJ; Esko JD; Lübke T; Dierks T
    Biochem J; 2020 Sep; 477(17):3433-3451. PubMed ID: 32856704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
    Sawamoto K; Álvarez González JV; Piechnik M; Otero FJ; Couce ML; Suzuki Y; Tomatsu S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse.
    Vogler C; Levy B; Galvin N; Lessard M; Soper B; Barker J
    Pediatr Dev Pathol; 2005; 8(4):453-62. PubMed ID: 16222480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.
    Kingma SDK; Wagemans T; IJlst L; Bronckers ALJJ; van Kuppevelt TH; Everts V; Wijburg FA; van Vlies N
    Bone; 2016 Jul; 88():92-100. PubMed ID: 27105565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities.
    Wilson S; Hashamiyan S; Clarke L; Saftig P; Mort J; Dejica VM; Brömme D
    Am J Pathol; 2009 Nov; 175(5):2053-62. PubMed ID: 19834056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients.
    Bhalla A; Ravi R; Fang M; Arguello A; Davis SS; Chiu CL; Blumenfeld JR; Nguyen HN; Earr TK; Wang J; Astarita G; Zhu Y; Fiore D; Scearce-Levie K; Diaz D; Cahan H; Troyer MD; Harris JM; Escolar ML
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers in patients with mucopolysaccharidosis type II and IV.
    Fujitsuka H; Sawamoto K; Peracha H; Mason RW; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab Rep; 2019 Jun; 19():100455. PubMed ID: 30775257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders.
    McGlynn R; Dobrenis K; Walkley SU
    J Comp Neurol; 2004 Dec; 480(4):415-26. PubMed ID: 15558784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I.
    Pievani A; Azario I; Antolini L; Shimada T; Patel P; Remoli C; Rambaldi B; Valsecchi MG; Riminucci M; Biondi A; Tomatsu S; Serafini M
    Blood; 2015 Mar; 125(10):1662-71. PubMed ID: 25298037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses.
    Langereis EJ; Wagemans T; Kulik W; Lefeber DJ; van Lenthe H; Oussoren E; van der Ploeg AT; Ruijter GJ; Wevers RA; Wijburg FA; van Vlies N
    PLoS One; 2015; 10(9):e0138622. PubMed ID: 26406883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrastructural analysis of different skeletal cell types in mucopolysaccharidosis dogs at the onset of postnatal growth.
    Jiang Z; Lau YK; Wu M; Casal ML; Smith LJ
    J Anat; 2021 Feb; 238(2):416-425. PubMed ID: 32895948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.